NRG-GY028

A phase IB and randomized phase II trial of megestrol acetate with or without ipatasertib in recurrent or metastatic endometrioid endometrial cancer.
Status:

Open

Trial Type:

Contact:

Dr. Cara Mathews
cmathews@wihri.org